lobbying_activities: 3044714

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3044714	b915aaef-b8fc-42dc-bebf-12f93c1b2adf	Q3	WATKINS & EAGER PLLC	401104403	ZYNERBA PHARMACEUTICALS, INC.	2023	third_quarter	PHA	Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.	HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2023-10-04T11:16:34-04:00